Lung Cancer Clinical Trial

Clinical Trial Finder Lung Cancer Trials

An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed

Summary

This large, non-randomized observational study is being conducted to provide data about the impact of ethnic origin on outcomes and resource utilization during the 2nd line treatment of non-small cell lung cancer (NSCLC) in a routine medical care setting.

View Full Description

Full Description

This is a large 1000 patient single arm observational study being conducted to determine the impact of ethnic origin (Caucasian, African-Americans, Asian-Americans, and Hispanics) on patients being treated for 2nd line advanced NSCLC with pemetrexed given in routine clinical practice. Data will be collected on disease control rate by pemetrexed as defined by Response Rate (RR) (Complete Response (CR) + Partial Response (PR)), Stable Disease (SD) and toxicities. In addition, overall survival, progression-free survival, treatment toxicities, activities of daily living, symptom burden and resource utilization will also be observed. To meet the study goals, a total of 400 Caucasians, 200 African- Americans, 200 Asian-Americans, and 200 Hispanics will be accrued to this study.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Non-small cell lung cancer (NSCLC) (any histologic type)
Stage IIIB or IV disease
Should have had 1 line of chemotherapy for Metastatic disease
Adequate hematologic, hepatic and renal function
Measurable or evaluable disease

Exclusion Criteria:

Pregnant or lactating females

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 38 Locations for this study

See Locations Near You

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Mobile Alabama, 36608, United States

How clear is this clinincal trial information?

Easy to understand
Somewhat clear
Difficult to understand

Multiple Myeloma

Discover local Multiple Myeloma resources:

Ovarian Cancer

Discover local Ovarian Cancer resources:

Multiple Myeloma: Main Page

Discover local Multiple Myeloma resources:

Discover Local Multiple Myeloma resources:

Ovarian Cancer: Main Page

Discover local Ovarian Cancer resources:

Discover Local Ovarian Cancer resources:

Clinical Trial Finder Lung Cancer Trials

An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed

Summary

Full Description

Eligibility Criteria

Study is for people with:

Estimated Enrollment:

Study ID:

Recruitment Status:

Sponsor:

Check Your Eligibility

There are 38 Locations for this study

Study is for people with:

Estimated Enrollment:

Study ID:

Recruitment Status:

Sponsor:

Introducing, the Journey Bar

Multiple Myeloma

Discover local Multiple Myeloma resources:

Ovarian Cancer

Discover local Ovarian Cancer resources:

Multiple Myeloma: Main Page

Discover local Multiple Myeloma resources:

Discover Local Multiple Myeloma resources:

Ovarian Cancer: Main Page

Discover local Ovarian Cancer resources:

Discover Local Ovarian Cancer resources:

Clinical Trial Finder Lung Cancer Trials

An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed

Summary

Full Description

Eligibility Criteria

Study is for people with:

Estimated Enrollment:

Study ID:

Recruitment Status:

Sponsor:

Check Your Eligibility

There are 38 Locations for this study

Study is for people with:

Estimated Enrollment:

Study ID:

Recruitment Status:

Sponsor:

Clinical Trial Resources

Get SurvivorNet in Your Inbox

Introducing, the Journey Bar

Please confirm you are a US based health care provider: